Skip to content

Role of Dadru Gajendra sinh lepa vs terbinafine ointment in the management of Tinea cruris

Comparative Clinical Study To Evaluate The Efficacy Of Dadru Gajendra Sinh Lepa And Terbinafine Ointment In Management Of Dadru Kushtha W.R.T Tinea Cruris . - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054377
Enrollment
80
Registered
2023-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

Dr Priyanka Pandurang Panchal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i)Patients willing to participate in this trial through written informed consent ii)Patients who are 18 years to 70 years of any sed iii)Patients having specific symptoms of dadru kushtha iv)Patients who have controlled DM

Exclusion criteria

Exclusion criteria: i)Person with age below 18 years and with age above 70 years ii)Person having severe/chronic hepatic/renal diseases iii)Person with chronic infectious disease such as active Tuberculosis,Hepatitis B or C,or HIV iv)Chronicity more than 2 years v)Pregnant women and lactating mothers

Design outcomes

Primary

MeasureTime frame
Relief from subjective assessment criteria i.e clinical signs and symptoms of dadru kushta such as redness (raga),pustules (Pidaka), itching(kandu) ,number of mandals, size of mandalsTimepoint: Baseline,after 7 days for 21days

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Dnyneshwar M Padavi

Dr DY Patil school of Ayurveda, Navi Mumbai

dmpadavi@gmail.com9833158688

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026